Qualitative and quantitative evaluation of computed tomography changes in adults with cystic fibrosis treated with elexacaftor-tezacaftor-ivacaftor: a retrospective observational study

Introduction: The availability of highly effective triple cystic fibrosis transmembrane conductance regulator (CFTR) modulator combination therapy with elexacaftor–tezacaftor–ivacaftor (ETI) has improved pulmonary outcomes and quality of life of people with cystic fibrosis (pwCF). The aim of this st...

Descripción completa

Detalles Bibliográficos
Autores principales: Dettmer, Sabine, Weinheimer, Oliver, Sauer-Heilborn, Annette, Lammers, Oliver, Wielpütz, Mark O., Fuge, Jan, Welte, Tobias, Wacker, Frank, Ringshausen, Felix C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552920/
https://www.ncbi.nlm.nih.gov/pubmed/37808186
http://dx.doi.org/10.3389/fphar.2023.1245885

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552920/
https://www.ncbi.nlm.nih.gov/pubmed/37808186
http://dx.doi.org/10.3389/fphar.2023.1245885

Ejemplares similares